loading page

ASSESSMENT OF CLINICAL AND NEUROLOGICAL ALTERATIONS BEFORE RADIATION THERAPY IN CHILDREN WITH MALIGNANT BRAIN TUMOUR
  • +16
  • Mara Lecchi,
  • Alessandra Erbetta,
  • Paolo Grampa,
  • Claudia Cavatorta,
  • Silvia Meroni,
  • Anna Nigri,
  • Filippo Spreafico,
  • emilia pecori,
  • Maria Chiara Oprandi,
  • Veronica Biassoni,
  • Elisabetta Schiavello,
  • Denis Peruzzo,
  • Rita Laureanti,
  • Luca Mainardi,
  • Sabina Vennarini,
  • geraldina poggi,
  • Paolo Verderio,
  • Emanuele Pignoli,
  • Maura Massimino
Mara Lecchi
Fondazione IRCCS Istituto Nazionale dei Tumori
Author Profile
Alessandra Erbetta
Fondazione IRCCS Istituto Neurologico Carlo Besta
Author Profile
Paolo Grampa
Fondazione IRCCS Istituto Nazionale dei Tumori
Author Profile
Claudia Cavatorta
Fondazione IRCCS Istituto Nazionale dei Tumori
Author Profile
Silvia Meroni
Fondazione IRCCS Istituto Nazionale dei Tumori
Author Profile
Anna Nigri
Fondazione IRCCS Istituto Neurologico Carlo Besta
Author Profile
Filippo Spreafico
Fondazione IRCCS Istituto Nazionale dei Tumori
Author Profile
emilia pecori
Fondazione IRCCS Istituto Nazionale dei Tumori
Author Profile
Maria Chiara Oprandi
Istituto di Ricovero e Cura a Carattere Scientifico Eugenio Medea
Author Profile
Veronica Biassoni
Fondazione IRCCS Istituto Nazionale dei Tumori
Author Profile
Elisabetta Schiavello
Fondazione IRCCS Istituto Nazionale dei Tumori
Author Profile
Denis Peruzzo
Istituto di Ricovero e Cura a Carattere Scientifico Eugenio Medea

Corresponding Author:[email protected]

Author Profile
Rita Laureanti
Politecnico di Milano Dipartimento di Elettronica Informazione e Bioingegneria
Author Profile
Luca Mainardi
Politecnico di Milano Dipartimento di Elettronica Informazione e Bioingegneria
Author Profile
Sabina Vennarini
Fondazione IRCCS Istituto Nazionale dei Tumori
Author Profile
geraldina poggi
Istituto di Ricovero e Cura a Carattere Scientifico Eugenio Medea
Author Profile
Paolo Verderio
Fondazione IRCCS Istituto Nazionale dei Tumori
Author Profile
Emanuele Pignoli
Fondazione IRCCS Istituto Nazionale dei Tumori
Author Profile
Maura Massimino
Fondazione IRCCS Istituto Nazionale dei Tumori
Author Profile

Abstract

Purpose Young patients with a brain tumour show neurocognitive alterations as both consequences of the tumour and of the treatments received. In this paper, we present the basal analysis of a prospective study of damage from radiation after focal radiation therapy (RT), correlating tumour localization, symptoms, neurological/endocrinological impairments, surgery/ies±chemotherapy, and cognitive assessments at the time of enrolment. Methods Sixty-six children eligible for focal RT underwent a neurocognitive assessment. The demographic, pathological and clinical variables with MRI morphological scans, where differenypt kind of damage scores were defined, were then analysed. Results The patients’ median age was 8 years; the most frequent tumour was ependymoma (41%), and the posterior fossa (29%) was the prevalent site. All but 2 children (with germ cell tumours), had undergone surgery and 32 sessions of chemotherapy before irradiation. Ad-hoc scores for neurological deficits and endocre alterations were created and structural abnormalities were scored in each cortical/subcortical region. Patients with posterior fossa ependymomas and infratentorial tumours showed the highest score of neurological damage while endocrine alterations were more serious in patients with craniopharyngioma and germ cell tumours of the sellar region and ventricular system. The median number of structural damaged areas was equal to 2 for each child. Neurological deficit scores were not associated with the presence of hydrocephalus and surgery/ies received, unlike endocrine deficits. Conclusion The analysis of baseline evaluations highlights damage existing prior to radiation and generated by multiple factors. In light of these findings, damage over time should be investigated by distinguishing multiple generating factors.
13 Dec 2024Submission Checks Completed
13 Dec 2024Assigned to Editor
13 Dec 2024Submitted to Pediatric Blood & Cancer
16 Dec 2024Review(s) Completed, Editorial Evaluation Pending
17 Dec 2024Reviewer(s) Assigned